InflaRx N.V.
IFRXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $183.56M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.80$2.95
- Volume (live)
- -
- Avg. volume (3M)
- 662.55K
InflaRx (IFRX) Stock Price & Financial Analysis
InflaRx Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.48 - $1.59 |
|---|---|
| 52-Week High | $2.95 |
| 52-Week Low | $0.80 |
| Open | $1.51 |
| Volume (last close) | 889.58K |
| Average Volume (3M) | 662.55K |
| Revenue (TTM) | -11.31K |
|---|---|
| Net Income (TTM) | -43.82M |
| Free Cash Flow (TTM) | -26.83M |
| EPS (TTM) | −$0.54 |
| Return on Equity (ROE) | -26.78% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 183.56M |
|---|---|
| Shares Outstanding | 117.66M |
| Price to Book (P/B) | 1.12 |
| EV/EBITDA | -0.42 |
| 50-Day MA | $1.94 |
|---|---|
| 200-Day MA | $1.62 |
| 1-Year Change | +25.41% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
InflaRx at a Glance
As of the Oct 23, 2026 close, InflaRx (IFRX) has a market capitalization of $183.56M. Over the trailing twelve months it lost $43.82M on revenue of −$11.31K and burned $26.83M of free cash flow. Revenue fell 106.2% year over year.
As of its latest reported balance sheet, it holds $164.06M in cash and securities against $932.48K of debt, a net cash position of $163.13M.
InflaRx does not currently pay a dividend.
The share price is up 25.4% over the past year. At $1.56 (the Oct 23, 2026 close) it sits within its 52-week range of $0.80 to $2.95, below its 200-day moving average of $1.62.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $6.75, 332.7% above the Oct 23, 2026 close.
Frequently Asked Questions About InflaRx
What is the current stock price for IFRX?
As of the Oct 23, 2026 close, IFRX stock trades at $1.56. The 52-week range is $0.80–$2.95, with a day range of $1.48–$1.58.
What is the P/E ratio for IFRX?
The P/E ratio (Price-to-Earnings) for IFRX is shown in the Key Statistics section. This valuation metric helps compare InflaRx N.V. to industry peers.
Does IFRX pay dividends?
InflaRx does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IFRX?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for IFRX is Buy. The average 12-month price target is $6.75, a 332.7% upside from the Oct 23, 2026 close of $1.56.
What is the market cap of IFRX?
As of the Oct 23, 2026 close, InflaRx's market capitalization is $183.6M, classifying it as a micro-cap company. InflaRx operates in the Healthcare sector within the Biotechnology industry.